• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

Roles of type II alveolar epithelial cells in T cell-dependent immune response in Mycobacterium tuberculosis infection

Research Project

Project/Area Number 13670601
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionSHIMANE MEDICAL UNIVERSITY

Principal Investigator

SATO Katsumasa  SHIMANE MEDICAL UNIVERSITY, MICROBIOLOGY AND IMMUNOLOGY, INSTURUCTOR, 医学部, 助手 (00142331)

Co-Investigator(Kenkyū-buntansha) SHIMIZU Toshiaki  SHIMANE MEDICAL UNIVERSITY, MICROBIOLOGY AND IMMUNOLOGY, INSTURUCTOR, 医学部, 助手 (60284030)
TOMIOKA Haruaki  SHIMANE MEDICAL UNIVERSITY, MICROBIOLOGY AND IMMUNOLOGY, PROFESSOR, 医学部, 教授 (40034045)
Project Period (FY) 2001 – 2002
KeywordsM.tuberculosis / M.avium complex / type II alveolar pneumocytes / lymphocytes / macrophages / A-549 cells / PBMC / cytokines
Research Abstract

Our previous study revealed that both Mycobacterium tuberculosis (MTB) and M.avium complex (MAC) organisms invade type II alveolar epithelial cells in the lungs when mice are subjected to mycobacterial challenge via the intracheal route. In addition, MTB- or MAC-infected A-549 human type II alveolar epithelial cells (A-549 cells) release humoral factors (TNF-α and GM-CSF), thereby increasing antimycobacterial activity of macrophages(Mφs). In this study, the following findings have been obtained. (1) Anti-TNF-α and anti-GM-CSF antibodies attenuated A-549 cell-dependent inhibition of the intramacrophage growth of MTB and MAC, indicating crucial roles of these cytokines in A-549 cell-mediated potentiation of Mφ antimycobacterial activity. (2) When human peripheral blood mononuclear cells (PBMC) were added onto MTB-infected A-549 cells and Con A- or PPD-induced T cell mitogenesis was examined, T cell mitogenosis in the presence of A-549 cells was inhibited more profoundly than cases without A-549 cells. Such an inhibitory effect was also observed for A-549 cells without MTB infection. When a dual chamber system was used to prevent the cell contact between PBMC and A-549 cells, similar results were also obtained. Therefore, it is thought that the observed inhibition of PBMC mitogenesis due to A-549 cells is dependent upon some unknown humoral T cell-inhibitory factors released from A-549 cells.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Tomioka H: "Type II pneumocytes in the evaluation of drug antimycobacterial activity"Expert Opin Pharmacother. 4. 127-139 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: "Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines"J Infect Dis. 185. 1139-1147 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sano K, Sato K, Sano C, Shimizu T, Tomioka H: "Comparative profiles of intramacrophage behavior of Mycobacterium tuberculosis and Mycobacterium avium complex with different levels of virulence"Microbiol Immunol. 46. 483-486 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogasawara K, Tomioka H, Shimizu T, Sano C, Kawauchi H, Sato K: "Profiles of cell-to-cell interaction of Mycobacterium intracellulare -induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission"Clin Exp Immunol. 129. 272-280 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomioka H, Sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs"J Infection. 44. 160-165 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 佐藤勝昌, 冨岡治明, 清水利朗, 佐野千晶, 佐野啓介, 松島敏春: "マクロファージ内順化Mycobacterium tuberculosisおよびMycobacterium avium complexに対する各種抗菌薬の殺菌作用"日本化学療法学会雑誌. 50. 288-291 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 冨岡治明: "細菌学(竹田美文, 林 英生 編)、分担執筆"朝倉書店. 563-572 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomioka H: "Type II pneumocytes in the evaluation of drug antimycobacterial activity"Expert Opin Pharmacother. 4. 127-139 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: "Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines"J Infect Dis. 1139-1147 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato K, Tomioka H, Shimizu T, Gonda T, Ota F, Sano C: "Type II alveolar cells plays roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines"J Infect Dis. 1139-1147 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ogasawara K, Tomioka H, Shimizu T, Sano C, Kawauchi H, Sato K: "Profiles of cell-to-cell interaction of Mycobacterium intracellulare -induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission"Clin Exp Immunol. 129. 272-280 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tomioka H, Sato K, Shimizu T, Sano C: "Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs"J Infection. 44. 160-165 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato K, Tomioka H, Shimizu, T Sano C, Sano K, Matsushima T: "Altered susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to rifalazil, clarithromycin, and levofloxacin after adaptation to intramacrophage milieus as determined by intracellular susceptibility testing"Jpn Society Chemother. 50. 288-291 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi